Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foreal BioTech is a biotechnology company established in 2016 that specializes in the manufacture and distribution of high-quality phytochemicals, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company is a prominent supplier in the hyaluronic acid (HA) market, offering various grades of sodium hyaluronate produced through advanced microbial fermentation for the medical, cosmetic, and food industries. Beyond HA, Foreal BioTech provides a diverse portfolio of products including chondroitin sulfate, herbal extracts, and cosmetic peptides such as argireline. The company supports global clients from initial R&D through to market promotion, offering formulation application services and innovation support for personal care and pharmaceutical development. Headquartered in California, Foreal BioTech emphasizes high-quality production and fast delivery to meet the demands of the global health and beauty sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foreal BioTech.